Eric B Larson

Dr. Eric B Larson

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2006 in Annals of Internal Medicine
Verified
Journal Article
Open access
PDF file
ELEric B Larson
Eric B Larson
LWLi Wang
Li Wang
JBJames D. Bowen
James D. Bowen
WMWayne C. McCormick
Wayne C. McCormick
LTLinda Teri
Linda Teri
WKWalter Kukull
Walter Kukull
Alzheimer disease and other dementing disorders are major sources of morbidity and mortality in aging societies. Proven strategies to delay onset or reduce risk for dementing disorders would be greatly beneficial. To determine whether regular exercise is associated with a reduced risk for dementia and Alzheimer disease. Prospective cohort study. Group Health Cooperative, Seattle, Washington. 1740 persons older than age 65 years without cognitive impairment who scored above the 25th percentile on the Cognitive Ability Screening Instrument (CASI) in the Adult Changes in Thought study and who were followed biennially to identify incident dementia. Baseline measurements, including exercise frequency, cognitive function, physical function, depression, health conditions, lifestyle characteristics, and other potential risk factors for dementia (for example, apolipoprotein E ϵ4); biennial assessment for dementia. During a mean follow-up of 6.2 years (SD, 2.0), 158 participants developed dementia (107 developed Alzheimer disease). The incidence rate of dementia was 13.0 per 1000 person-years for participants who exercised 3 or more times per week compared with 19.7 per 1000 person-years for those who exercised fewer than 3 times per week. The age- and sex-adjusted hazard ratio of dementia was 0.62 (95% CI, 0.44 to 0.86; P = 0.004). The interaction between exercise and performance-based physical function was statistically significant (P = 0.013). The risk reduction associated with exercise was greater in those with lower performance levels. Similar results were observed in analyses restricted to participants with incident Alzheimer disease. Exercise was measured by self-reported frequency. The study population had a relatively high proportion of regular exercisers at baseline. These results suggest that regular exercise is associated with a delay in onset of dementia and Alzheimer disease, further supporting its value for elderly persons.

1 March 2015 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
SGShelly Lynn Gray
Shelly Lynn Gray
MAMelissa L. Anderson
Melissa L. Anderson
SDSascha Dublin
Sascha Dublin
JHJoseph T. Hanlon
Joseph T. Hanlon
RHRebecca Hubbard
Rebecca Hubbard
ELEric B Larson
Eric B Larson
Medications with anticholinergic activity are used widely by older adults for diverse conditions, such as overactive bladder, seasonal allergies, and depression. Some anticholinergics achieve the intended therapeutic outcome by blocking the effect of acetylcholine at the muscarinic receptor within specific organ systems (eg, antispasmodics for the gastrointestinal tract, antimuscarinics for the bladder, and antiparkinsonians). However, other medications have unintended anticholinergic effects that are not the primary therapeutic activity (eg, first-generation antihistamines, tricyclic antidepressants, and certain antipsychotics).

26 January 2011 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
TTthe eMERGE Team
the eMERGE Team
CMCatherine A McCarty
Catherine A McCarty
RCRex L Chisholm
Rex L Chisholm
CCChristopher G Chute
Christopher G Chute
Iftikhar KulloIftikhar Kullo
Iftikhar Kullo
WWWendy A Wolf
Wendy A Wolf
The eMERGE (electronic MEdical Records and GEnomics) Network is an NHGRI-supported consortium of five institutions to explore the utility of DNA repositories coupled to Electronic Medical Record (EMR) systems for advancing discovery in genome science. eMERGE also includes a special emphasis on the ethical, legal and social issues related to these endeavors. The five sites are supported by an Administrative Coordinating Center. Setting of network goals is initiated by working groups: (1) Genomics, (2) Informatics, and (3) Consent & Community Consultation, which also includes active participation by investigators outside the eMERGE funded sites, and (4) Return of Results Oversight Committee. The Steering Committee, comprised of site PIs and representatives and NHGRI staff, meet three times per year, once per year with the External Scientific Panel. The primary site-specific phenotypes for which samples have undergone genome-wide association study (GWAS) genotyping are cataract and HDL, dementia, electrocardiographic QRS duration, peripheral arterial disease, and type 2 diabetes. A GWAS is also being undertaken for resistant hypertension in ≈2,000 additional samples identified across the network sites, to be added to data available for samples already genotyped. Funded by ARRA supplements, secondary phenotypes have been added at all sites to leverage the genotyping data, and hypothyroidism is being analyzed as a cross-network phenotype. Results are being posted in dbGaP. Other key eMERGE activities include evaluation of the issues associated with cross-site deployment of common algorithms to identify cases and controls in EMRs, data privacy of genomic and clinically-derived data, developing approaches for large-scale meta-analysis of GWAS data across five sites, and a community consultation and consent initiative at each site. Plans are underway to expand the network in diversity of populations and incorporation of GWAS findings into clinical care. By combining advanced clinical informatics, genome science, and community consultation, eMERGE represents a first step in the development of data-driven approaches to incorporate genomic information into routine healthcare delivery.

11 January 2012 in JAMA
Verified
Journal Article
Open access
PDF file
EPElizabeth A Phelan
Elizabeth A Phelan
SBSoo Borson
Soo Borson
LGLouis Grothaus
Louis Grothaus
SBSteven Balch
Steven Balch
ELEric B Larson
Eric B Larson
Claims-based, retrospective studies have long reported that dementia is associated with increased hospitalizations,1-9 but empirical data to elucidate this finding are few. Suboptimal management in the outpatient setting may be a contributing factor, as suggested by lower prescription drug costs and fewer office visits after diagnosis.4 Accomplishing adequate chronic disease management is more difficult in persons with dementia, which may lead to hospitalization for acute exacerbation of comorbid conditions.4,5 Nonelective hospitalization of older people, particularly those with dementia, is not a trivial event. Among older persons without dementia, hospitalization for serious illness is associated with subsequent cognitive decline,10 and frail elders, including those with dementia, are at increased risk of delirium, functional decline, and iatrogenic complications during an inpatient stay.11-13 Identifying conditions that precipitate hospitalization of elderly individuals with dementia could focus clinical priorities on secondary and tertiary prevention in the outpatient setting and improve health care for this vulnerable and increasing population. We used a unique longitudinal data set to determine whether dementia onset is associated with higher rates of or different reasons for hospitalization, particularly for ambulatory care–sensitive conditions (ACSCs), for which proactive outpatient care might prevent the need for a hospital stay.

6 April 2004 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
ELEric B Larson
Eric B Larson
MSMarie-Florence Shadlen
Marie-Florence Shadlen
LWLi Wang
Li Wang
WMWayne C. McCormick
Wayne C. McCormick
JBJames D. Bowen
James D. Bowen
WKWalter A. Kukull
Walter A. Kukull
Alzheimer disease is an increasingly common condition in older people. Knowledge of life expectancy after the diagnosis of Alzheimer disease and of associations of patient characteristics with survival may help planning for future care. To investigate the course of Alzheimer disease after initial diagnosis and examine associations hypothesized to correlate with survival among community-dwelling patients with Alzheimer disease. Prospective observational study. An Alzheimer disease patient registry from a base population of 23 000 persons age 60 years and older in the Group Health Cooperative, Seattle, Washington. 521 newly recognized persons with Alzheimer disease enrolled from 1987 to 1996 in an Alzheimer disease patient registry. Baseline measurements included patient demographic features, Mini-Mental State Examination score, Blessed Dementia Rating Scale score, duration since reported onset of symptoms, associated symptoms, comorbid conditions, and selected signs. Survival was the outcome of interest. The median survival from initial diagnosis was 4.2 years for men and 5.7 years for women with Alzheimer disease. Men had poorer survival across all age groups compared with females. Survival was decreased in all age groups compared with the life expectancy of the U.S. population. Predictors of mortality based on proportional hazards models included a baseline Mini-Mental State Examination score of 17 or less, baseline Blessed Dementia Rating Scale score of 5.0 or greater, presence of frontal lobe release signs, presence of extrapyramidal signs, gait disturbance, history of falls, congestive heart failure, ischemic heart disease, and diabetes at baseline. The base population, although typical of the surrounding Seattle community, may not be representative of other, more diverse populations. In this sample of community-dwelling elderly persons who received a diagnosis of Alzheimer disease, survival duration was shorter than predicted on the basis of U.S. population data, especially for persons with onset at relatively younger ages. Features significantly associated with reduced survival at diagnosis were increased severity of cognitive impairment, decreased functional level, history of falls, physical examination findings of frontal release signs, and abnormal gait. The variables most strongly associated with survival were measures of disease severity at the time of diagnosis. These results should be useful to patients and families experiencing Alzheimer disease, other caregivers, clinicians, and policymakers when planning for future care needs.

1 September 2016 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
PCPaul Crane
Paul Crane
LGLaura E. Gibbons
Laura E. Gibbons
KDKristen Dams-O’cOnnor
Kristen Dams-O’cOnnor
ETEmily Trittschuh
Emily Trittschuh
JLJames B. Leverenz
James B. Leverenz
ELEric B Larson
Eric B Larson
Each year, many people experience a traumatic brain injury (TBI). Quiz Ref ID Most TBIs are mild, and most people return to prior levels of functioning. Worry about late effects of TBI has magnified in recent years with media coverage of chronic traumatic encephalopathy in athletes with repetitive head trauma.1,2 Head injury is the signature injury of recent military conflicts.3 Many TBIs are not related to sports or combat. Characterizing the late-life effects of nonrepetitive TBIs in nonathlete civilians is important.4